EUCTR2017-002461-21-IT进行中（未招募）1 期
A Phase IIb, prospective, intra-patient randomised controlled, multicentre study to evaluate the safety and efficacy of an autologous bio-engineered dermo-epidermal skin substitute (EHSG-KF) for the treatment of partial deep dermal and full thickness burns in children in comparison to autologous split-thickness skin grafts (STSG)
niversity of Zurich, Tissue Biology Research Unit0 个研究点目标入组 12 人开始时间: 2019年12月13日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •? Age: 1-17 years of age
- •? Deep partial thickness and/or full-thickness burns requiring
- •surgical wound coverage
- •? The following two criteria must be met:
- •o Expected that =90cm2 of wound (not counting the head
- •and neck area for study patients in The Netherlands) will
- •remain open at 4 weeks post burn despite proceeding with
- •treatment in accordance with the standard of care,
- •o >25% TBSA burn
- •? Signed Informed consent from the patient or the parents/legally
- •authorized representative.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 12
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •? Patients tested positive for HBV, HCV, syphilis or HIV
- •? Patients with known underlying or concomitant medical conditions
- •that may interfere with normal wound healing (e.g. systemic skin
- •and connective tissue diseases, any kind of congenital defect of
- •metabolism including insulin-dependent diabetes mellitus,
- •Cushing syndrome or disease, scurvy, chronic hypothyroidism,
- •congenital or acquired immunosuppressive condition, chronic
- •renal failure, or chronic hepatic dysfunction (Child-Pugh class B or
- •C), severe malnutrition, or other concomitant illness which, in the
- •opinion of the Investigator, has the potential to significantly delay
- •wound healing)
- •? Severe drug and alcohol abuse
- •? Patients with a known history of malignancy
- •? Pre-existing coagulation disorders as defined by INR outside its
- •normal value, PTT >ULN and fibrinogen hospital admission and / or at the Investigator’s discretion
- •? Patients allergic to amphotericin B and gentamicin
- •? Previous enrolment of the patient into the current phase II study
- •? Participation of the patient in another study with conflicting
- •endpoints within 30 days preceding and during the present study
- •? Patients or parents/ legally authorized representative expected
- •not to comply with the study protocol (including patients with
- •severe cognitive dysfunction/impairment and severe psychiatric
- •? Pregnant or breast feeding females
- •? Suspicion of child abuse
- •? Wounds in the head and neck area as study target area (only
- •applicable for study patients in The Netherlands)
- •? Enrolment of the Investigator, his/her family members, employees
- •and other dependent persons
研究者
相似试验
进行中（未招募）
1 期
A study performed in more hospitals, to assess the safety and efficacy of a skin model that is engineered in the lab with cells of the patient (EHSG-KF) to use in treatment of partial deep dermal and full thickness burns in children and compare this to the treatment with the own skin system called STSG.Children with partial deep dermal and full thickness burnsEUCTR2017-002461-21-NLCUTISS AG12
招募中
2 期
A Phase IIb, prospective, intra-patient randomised controlled, multicentre study to evaluate the safety and efficacy of an autologous bio-engineered dermo-epidermal skin substitute (EHSG-KF) for the treatment of partial deep dermal and full thickness burns in adults and adolescents in comparison to autologous split-thickness skin grafts (STSG)ernstige brandwondendermal burnsskin damage due to heatNL-OMON55581CUTISS AG4
尚未招募
2 期
A Phase IIb, prospective, intra-patient randomised controlled, multicentre study to evaluate the safety and efficacy of an autologous bio-engineered dermo-epidermal skin substitute (EHSG-KF) for the treatment of partial deep dermal and full thickness burns in children in comparison to autologous split-thickness skin grafts (STSG)ernstige brandwondendermal burnsskin damage due to heatNL-OMON55737CUTISS AG4
进行中（未招募）
1 期
A study to check if the use of a skin model engeneered in the laboratory by using your own skin cells (EHSG-KF), is safe and effective to treat partial deep dermal and full thickness burns in adults in comparison to the standard treatment used in current medicine (STSG).EUCTR2017-002460-41-ITniversity of Zurich, Tissue Biology Research Unit12
进行中（未招募）
1 期
A study to check if the use of a skin model engeneered in the laboratory by using your own skin cells (EHSG-KF), is safe and effective to treat partial deep dermal and full thickness burns in adults and adolescents in comparison to the standard treatment used in current medicine (STSG).Adults and adolescents with partial deep dermal and full thickness burnsEUCTR2017-002460-41-NLCUTISS AG12